Senior Cardiovascular Biopharmaceutical Representative. Successfully launched Praluent (first-in-class PCSK9 inhibitor, subq injectables monoclonal antibody to lower LDL-C). Identify top cholesterol prescribers in the territory and educate staff and providers about Praluent. Call points Cardiology, Lipidology, Endocinology, and PCP. Responsibilities include but not limited to; working collaboratively with Reimbursement specialist, Clinical Nurse Educator, Specialty Pharmacy, HUB, Prior Authorization office staff, office nurse, office manager, case managers. Create awareness of Heterozygous Familial Hypercholesterolemia an inherited gene cause high levels of LDL-C. Current rank in region #7 out of 72. Award for leadership for launch success of Praluent "Redefining Possible award" Current market share 57%

I am currently contributing to the success of AstraZeneca by implementing regional sales and sales support efforts to drive revenue growth of Symbicort and Crestor. But due to my extensive Cardiovascular experience I was also ask to launch Brilinta (anti-platelet). After securing a successful launch and uptake with Brilinta I was moved to focus more attention to Crestor and Symbicort.I have experience selling in broad therapeutic areas which include, Pulmonology, (COPD, Asthma), Cardiovascular Invasive Specialist, Endocrinology, Neurology, and Hospital, primary care, and Cath-Lab experience. Evidence of my Success can be demonstrated by results including:• Organizing a launch strategy for the district with Brilinta• Gaining access through P&T committees and writing hospital protocols • Increasing Brilinta awareness to primary care and family practice physicians• 2014: Q1 ranking #1 highest portfolio market share in district. #1/9• 2014: Turned around underperforming product (Symbicort) 89% to 100• 2014: Lead product #1 109% to goal District• 2014 Manage Care Champion• 2013: Generated and exceeded expectations of Q3 Crestor

Generate sales growth of Diovan, Exforge and Exforge HCT,Valturna, Tekturna, Valturna (Cardiovascular anti-hypertensive medications), Excelon Patch(Alzheimer’s/Parkinson’s dementia) and Recast (osteoporosis) whichrequires working with Long Term Care facilities, Medical Directors, Director of Nursing, and staff through sales calls and in-services . These disease states requires a call plan of Hospitals, LTC facilities, Neuphrologist, Endocrinologist and neurologists, throughout a large geographic territory covering East Tennessee and Southwest Virginia.Awards:• Successful implemented sales strategy with Exelon Patch in Q4 2011 and ranked #1 East Coast; achieved 242%to goal and finished 2011 ranked #189 out of 594.• Finished 2010 rank #76 out of 294 and led territory strategy implementing a collaborative call plan.• Won 2009 Rookie of the Year National Award for sales growth and territory turnaround. Promoted to PortfolioRep and Pod Leader in 2010.• Following territory realignment in 2009 with expanded physician base, continued to achieve strong sales results and ranked #16 out of 111.• Assigned to an underperforming territory in 2008 (#65 out of #66 territories in region) and successfully implemented sales efforts driving ranking to #1 in the region within 6 months.

Called on new/existing residential and commercial clients to sell phone, cable, and internet packages; schedule in-home appointments; and generate referrals.

Increased sales of residential and commercial security/surveillance systems, equipment, and services by securing new accounts through self-generated leads and cold calling efforts. Conducted comprehensive security analyses to determine needs and made in-home sales presentations that sold benefits of home security systems.